FDA Approves Breast-Cancer Drug
Updated Feb. 22, 2013 5:24 p.m. ET 
 
WASHINGTONâ€”The U.S. Food and Drug Administration on Friday approved a new type of drug that will be marketed by Roche Holding AG to treat breast cancer.
The drug called, Kadcyla, combines Roche's existing cancer drug, Herceptin, with a powerful chemotherapy agent and is meant to treat certain types of breast cancer that have spread to other parts of the body.
Herceptin targets a protein called HER2 found on tumors in about 20%... 
RELATED VIDEO
The FDA on Friday approved a powerful new type of drug from Roche to treat breast cancer. WSJ's Jennifer Corbett Dooren joins The News Hub with a look at what this means for patients, and some insight into the drug approval process. Photo: Getty Images.
 To Read the Full Story
